
60 Degrees Pharmaceuticals, Inc.
SXTPHealthcare|Biotechnology|US
$0.59
-0.32 (-35.08%)
Tangible Book / Share
$0.84
Cash / Share
$0.39
Next Earnings Report
Nov 12, 2026
EPS est. -$0.61 · Revenue est. $270.0K
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Aug 14, 2026 (S-3). Possible dilution.
Upcoming Data Readouts (2)
Feb 2027
Est. completion
Mar 2027
Est. completion
P2Babesiosis
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis
NCT06207370n=33
Recent Press Releases
60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome
Oct 28, 2026 · GlobeNewsWire
60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients
Oct 27, 2026 · GlobeNewsWire
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
Oct 6, 2026 · GlobeNewsWire
60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar
Oct 1, 2026 · GlobeNewsWire
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026 · GlobeNewsWire
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
Aug 14, 2026 · GlobeNewsWire
SEC Filings (77)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | 8-K | Material event | DocumentIndex |
| Oct 27, 2026 | 8-K | Material event | DocumentIndex |
| Oct 23, 2026 | 8-K | Material event | DocumentIndex |
| Oct 6, 2026 | 8-K | Material event | DocumentIndex |
| Sep 14, 2026 | 8-K | Material event | DocumentIndex |
| Sep 8, 2026 | 8-K | Material event | DocumentIndex |
| Aug 25, 2026 | EFFECT | DocumentIndex | |
| Aug 17, 2026 | DEL AM | DocumentIndex | |
| Aug 14, 2026 | S-3 | Shelf registration | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Aug 5, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 4, 2026 | 8-K | Material event | DocumentIndex |
| Jul 29, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 20, 2026 | 8-K | Material event | DocumentIndex |
| Jul 9, 2026 | 8-K | Material event | DocumentIndex |
| Jul 2, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 8, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 3, 2026 | 8-K | Material event | DocumentIndex |
| May 18, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Mar 30, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 20, 2026 | 8-K | Material event | DocumentIndex |
| Mar 13, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 13, 2026 | 8-K | Material event | DocumentIndex |
| Mar 12, 2026 | 8-K | Material event | DocumentIndex |
| Mar 11, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 2, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Feb 12, 2026 | 8-K | Material event | DocumentIndex |
| Jan 23, 2026 | 8-K | Material event | DocumentIndex |
| Jan 21, 2026 | 8-K | Material event | DocumentIndex |
| Jan 8, 2026 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 7, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 7, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 10, 2025 | 8-K | Material event | DocumentIndex |